跳到主要內容

Anderson Elizabeth M 的 Form 4 申報

Revolution Medicines, Inc.RVMD,2026/9/24 申報

申報編號
0001758247-26-000004
申報時間
2026/9/24 18:00 ET
交易日
2026/9/22
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 6 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $195.8 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Anderson Elizabeth MCIK 0001758247董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/9/22Common StockM行使選擇權取得+5,070$1.12+$5,678.414,476直接
2026/9/22Common StockS賣出處分−910$191.85F2−$174,585.4113,566直接
2026/9/22Common StockS賣出處分−4,985$192.54F3−$959,805.428,581直接
2026/9/22Common StockS賣出處分−2,648$193.44F4−$512,2275,933直接
2026/9/22Common StockS賣出處分−1,500$194.59F5−$291,883.054,433直接
2026/9/22Common StockS賣出處分−100$195.15−$19,5154,333直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/9/22Common StockM行使選擇權處分−6,165$0.00$01,095直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The transaction was executed in multiple trades at prices ranging from $191.65 to $191.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F3

The transaction was executed in multiple trades at prices ranging from $192.01 to $192.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F4

The transaction was executed in multiple trades at prices ranging from $193.00 to $193.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F5

The transaction was executed in multiple trades at prices ranging from $194.04 to $194.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)